Ankylosing spondylitis

Medicine

Volumn 34, Issue 10, 2006, Pages 396-400

  Calin, Andrei ^a  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

ankylosing spondylitis; HLA B27; psoriasis; sacroiliitis

Indexed keywords

ADALIMUMAB; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; ETORICOXIB; GOLD; HLA B27 ANTIGEN; INDOMETACIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ANKYLOSING SPONDYLITIS; CAUCASIAN; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; FATIGUE; FRACTURE; HUMAN; INCIDENCE; IRITIS; KINESIOTHERAPY; ONSET AGE; OSTEOPOROSIS; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; REVIEW; SEX RATIO; ULCERATIVE COLITIS;

EID: 33845371759     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.mpmed.2006.07.006     Document Type: Review

References (4)

1. Brophy S., Hamersma J., Bradbury L., et al. Towards defining the genetic determinants of disease severity in ankylosing spondylitis. Br J Rheum 40 1 (2001) 17
2. Brown M., and Calin A. Susceptibility to ankylosing spondylitis in twins - the role of genes, HLA and the environment. Arthritis Rheum 40 10 (1997) 1823-1828
3. Calin A., Brophy S., and Blake D. Impact of sex on the inheritance of ankylosing spondylitis: A cohort study. Lancet 354 (1999) 1687-1690
4. Braun J., Davis J., Doweados M., et al. First update of the International ASOS statement on the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65 (2006) 316-320